blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0937047

EP0937047 - 1-ARYLPHTHALAZINE ANTAGONISTS OF EXCITATORY AMINO ACID RECEPTORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.06.2005
Database last updated on 05.10.2024
Most recent event   Tooltip11.01.2008Lapse of the patent in a contracting state
New state(s): IT, PT		published on 13.02.2008  [2008/07]
Applicant(s)For all designated states
TRANSGENOMIC, Inc.
12325 Emmet Street
Omaha, NE 68164 / US
[2005/09]
Former [1999/34]For all designated states
Bearsden Bio, Inc.
34 Mount Pleasant Drive
Aston, Pennsylvania 19016 / US
Inventor(s)01 / COLLINS, Mark, A.
9 Craig Lane
Frazer, PA 19355 / US
[1999/34]
Representative(s)Hallybone, Huw George, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [1999/34]Hallybone, Huw George, et al
CARPMAELS AND RANSFORD 43 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date97904810.515.01.1997
[1999/34]
WO1997US00841
Priority number, dateUS1996058854918.01.1996         Original published format: US 588549
[1999/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9726247
Date:24.07.1997
Language:EN
[1997/32]
Type: A1 Application with search report 
No.:EP0937047
Date:25.08.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 24.07.1997 takes the place of the publication of the European patent application.
[1999/34]
Type: B1 Patent specification 
No.:EP0937047
Date:11.08.2004
Language:EN
[2004/33]
Search report(s)International search report - published on:EP24.07.1997
ClassificationIPC:C07D237/30, C07D491/04, A61K31/50
[1999/34]
CPC:
C07D491/04 (EP,US); A61K31/502 (EP,US); A61P25/08 (EP);
A61P25/18 (EP); A61P43/00 (EP); A61P9/00 (EP);
C07D237/30 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1999/34]
TitleGerman:ARYLPHTALAZINE ANTAGONISTEN VONEXITATONISCHEN AMINO SAÜRE REZEPTOREN[1999/34]
English:1-ARYLPHTHALAZINE ANTAGONISTS OF EXCITATORY AMINO ACID RECEPTORS[1999/34]
French:1-ARYLPHTHALAZINE ANTAGONISTE DE RECEPTEURS D'ACIDES AMINES EXCITATEURS[1999/34]
Entry into regional phase18.08.1998National basic fee paid 
18.08.1998Designation fee(s) paid 
18.08.1998Examination fee paid 
Examination procedure18.08.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
18.08.1998Examination requested  [1999/34]
26.02.2002Despatch of a communication from the examining division (Time limit: M06)
19.08.2002Reply to a communication from the examining division
17.01.2003Communication of intention to grant the patent
03.09.2003Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
15.09.2003Fee for grant paid
15.09.2003Fee for publishing/printing paid
Opposition(s)12.05.2005No opposition filed within time limit [2005/31]
Request for further processing for:15.09.2003Request for further processing filed
15.09.2003Full payment received (date of receipt of payment)
Request granted
21.01.2004Decision despatched
Fees paidRenewal fee
18.08.1998Renewal fee patent year 03
27.03.2000Renewal fee patent year 04
25.01.2001Renewal fee patent year 05
13.07.2002Renewal fee patent year 06
08.07.2003Renewal fee patent year 07
14.01.2004Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.01.200004   M06   Fee paid on   27.03.2000
31.01.200206   M06   Fee paid on   13.07.2002
31.01.200307   M06   Fee paid on   08.07.2003
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT11.08.2004
BE11.08.2004
CH11.08.2004
FI11.08.2004
IT11.08.2004
LI11.08.2004
NL11.08.2004
DK11.11.2004
GR11.11.2004
SE11.11.2004
ES22.11.2004
PT11.01.2005
LU15.01.2005
IE17.01.2005
MC31.01.2005
[2008/07]
Former [2007/17]AT11.08.2004
BE11.08.2004
CH11.08.2004
FI11.08.2004
LI11.08.2004
NL11.08.2004
DK11.11.2004
GR11.11.2004
SE11.11.2004
ES22.11.2004
LU15.01.2005
IE17.01.2005
MC31.01.2005
Former [2006/24]AT11.08.2004
BE11.08.2004
CH11.08.2004
FI11.08.2004
LI11.08.2004
NL11.08.2004
DK11.11.2004
GR11.11.2004
SE11.11.2004
ES22.11.2004
IE17.01.2005
MC31.01.2005
Former [2006/14]AT11.08.2004
BE11.08.2004
CH11.08.2004
FI11.08.2004
LI11.08.2004
DK11.11.2004
GR11.11.2004
SE11.11.2004
ES22.11.2004
MC31.01.2005
Former [2005/28]AT11.08.2004
BE11.08.2004
CH11.08.2004
FI11.08.2004
LI11.08.2004
DK11.11.2004
GR11.11.2004
SE11.11.2004
ES22.11.2004
Former [2005/23]AT11.08.2004
CH11.08.2004
FI11.08.2004
LI11.08.2004
DK11.11.2004
GR11.11.2004
SE11.11.2004
ES22.11.2004
Former [2005/22]AT11.08.2004
CH11.08.2004
FI11.08.2004
LI11.08.2004
DK11.11.2004
GR11.11.2004
SE11.11.2004
Former [2005/21]AT11.08.2004
CH11.08.2004
FI11.08.2004
LI11.08.2004
GR11.11.2004
SE11.11.2004
Former [2005/18]AT11.08.2004
FI11.08.2004
GR11.11.2004
SE11.11.2004
Former [2005/13]AT11.08.2004
FI11.08.2004
SE11.11.2004
Former [2005/11]FI11.08.2004
SE11.11.2004
Former [2005/10]SE11.11.2004
Cited inInternational search[A]EP0475527  (STERLING DRUG INC [US]) [A] 1,6 * page 56 - page 58; example 135; claim -; table G *;
 [PX]WO9640646  (SYMPHONY PHARM INC [US]) [PX] 1-17* the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.